Tenax Therapeutics Inc news

   Watch this stock
Showing stories 1 - 10 of about 62   

Articles published

TENX 3.32 +0.06 (1.84%)
price chart
Oxygen Biotherapeutics Announces Name Change to Tenax Therapeutics
Tenax Therapeutics, Inc., is a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market.
Beleagured Morrisville drug developer changes name, sharpens focus  Triangle Business Journal
Related articles »  
Tenax Therapeutics to Present at 2015 Wedbush PacGrow Healthcare Conference
MORRISVILLE, N.C., Aug 05, 2015 (BUSINESS WIRE) -- Tenax Therapeutics, Inc. TENX, +0.82% a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care market, today announced that John ...
Tenax Therapeutics Announces Nomination of James Mitchum to Board of Directors
Tenax Therapeutics, Inc. (TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care market, today announced that James Mitchum has been nominated to be elected to the Company's ...
Tenax Therapeutics Announces First Quarter Fiscal Year 2015 Financial Results
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), formerly Oxygen Biotherapeutics, Inc., a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, ...
Tenax Therapeutics' (TENX) CEO John Kelley on Q1 2015 Results - Earnings ...  Seeking Alpha (registration)
Related articles »  
Tenax Therapeutics Announces First Patients Enrolled in Phase 3 LEVO-CTS ...
Tenax Therapeutics, Inc. (formerly Oxygen Biotherapeutics) is a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market.
Morrisville's Tenax studies experimental drug in cardiac surgery patients  Triangle Business Journal
Related articles »  
Tenax Therapeutics Announces Fourth Quarter and Fiscal Year 2015 Financial Results
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced financial results for ...
Tenax Therapeutics Announces Appointment of Paula Bokesch, M.D., as Chief ...
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced the appointment of ...
Achillion Pharmaceuticals Inc (ACHN), Tenax Therapeutics Inc (TENX): Peter ...
In another move, the fund's manager, Peter Kolchinsky, has initiated a position in Tenax Therapeutics Inc (NASDAQ:TENX).
Related articles »  
Tenax Therapeutics Highlights New Scientific Publication Regarding the ...
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today highlighted a newly-published ...
UPDATE: MLV Initiates Coverage On Tenax Therapeutics
The United States Food and Drug Administration recently granted Fast Track status for levosimendan, and Tenax enrolled their first patient in the Phase III study in September.